2020
DOI: 10.3390/ijms21207735
|View full text |Cite
|
Sign up to set email alerts
|

DNA Methylation at Birth Predicts Intellectual Functioning and Autism Features in Children with Fragile X Syndrome

Abstract: Fragile X syndrome (FXS) is a leading single-gene cause of intellectual disability (ID) with autism features. This study analysed diagnostic and prognostic utility of the Fragile X-Related Epigenetic Element 2 DNA methylation (FREE2m) assessed by Methylation Specific-Quantitative Melt Analysis and the EpiTYPER system, in retrospectively retrieved newborn blood spots (NBS) and newly created dried blood spots (DBS) from 65 children with FXS (~2–17 years). A further 168 NBS from infants from the general populatio… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
12
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
7

Relationship

4
3

Authors

Journals

citations
Cited by 13 publications
(12 citation statements)
references
References 44 publications
(73 reference statements)
0
12
0
Order By: Relevance
“…The methylation silencing and mosaicism status of the FMR1 gene in the FXS participants in this study are not known. DNA methylation status of the CGG repeats in the FMR1 gene promoter at birth is predictive of later intellectual function and autism features [ 45 ]. The majority of males with FXS express some FMR1 mRNA and this incomplete silencing of the promoter is associated with increased autistic features [ 46 , 47 , 48 , 49 ], In males, full mutation FXS with complete or incomplete methylation silencing of the FMR1 gene is associated with increased inappropriate speech on the ABC-C sub-scale compared to the FXS group mosaic for pre- and full mutation alleles, and mosaicism in either sex is associated with less maladaptive behaviors [ 50 , 51 ].…”
Section: Discussionmentioning
confidence: 99%
“…The methylation silencing and mosaicism status of the FMR1 gene in the FXS participants in this study are not known. DNA methylation status of the CGG repeats in the FMR1 gene promoter at birth is predictive of later intellectual function and autism features [ 45 ]. The majority of males with FXS express some FMR1 mRNA and this incomplete silencing of the promoter is associated with increased autistic features [ 46 , 47 , 48 , 49 ], In males, full mutation FXS with complete or incomplete methylation silencing of the FMR1 gene is associated with increased inappropriate speech on the ABC-C sub-scale compared to the FXS group mosaic for pre- and full mutation alleles, and mosaicism in either sex is associated with less maladaptive behaviors [ 50 , 51 ].…”
Section: Discussionmentioning
confidence: 99%
“…Hypermethylation of the CpG island generates transcriptional silencing of the FMR1 gene. 23 As a consequence, the Fragile Mental Retardation Protein (FMRP), codified by the FMR1 gene, is not produced 24 and in turn, the absence or low expression of FMRP causes FXS. CGG tract repetition expansion in the untranslated region (UTR) of exon 1 in the FMR1 gene generates instability of that region during the replication process, inducing size mosaicism, which is defined as the presence of premutation and mutation alleles in several cells.…”
Section: First Level Of Categorization In Fxs Patients the Monogenic View: Alteration Of Fmr1 Functionmentioning
confidence: 99%
“…Hypermethylation of the CpG island generates transcriptional silencing of the FMR1 gene. 23 As a consequence, the Fragile Mental Retardation Protein (FMRP), codified by the FMR1 gene, is not produced 24 and in turn, the absence or low expression of FMRP causes FXS.…”
Section: First Level Of Categorization In Fxs Patients the Monogenic View: Alteration Of Fmr1 Functionmentioning
confidence: 99%
See 1 more Smart Citation
“…The clinical and molecular assessments were completed at the Murdoch Children's Research Institute, and the DNA methylation and FMR1 mRNA analysis reference data were analyzed previously as part of the FREE FX study (Kraan et al, 2020), with approval from The Royal-Children's Hospital Human Research Ethics Committee (Reference numbers: HREC 34227, HREC 33066, and HREC/13/RCHM/24).…”
Section: Participantsmentioning
confidence: 99%